Abstract
We have recently demonstrated that human TFF2 inhibits apoptosis in the non-TFF2 expressing breast adenocarcinoma cell line MCF-7. In this study we examined the impact of TFF2 and an anti-TFF2 antibody (hSP3) on the survival of other human adenocarcinoma cell lines; TFF2-positive (LS174T and SW480) and TFF2-negative (MCF-7 and T47D). Addition of TFF2 protected the (TFF2-) lines but had no effect on those constitutively expressing TFF2. Blocking with hSP3 significantly increased apoptosis in the (TFF2+) cell lines with minimal effect on the (TFF2-) cells. Our results show that the cytoprotective effect of TFF2 seen in MCF-7 cells is not cell line-specific and can be abrogated by inhibition of its expression.
| Original language | English (UK) |
|---|---|
| Pages (from-to) | 855-863 |
| Number of pages | 9 |
| Journal | Peptides |
| Volume | 25 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 2004 |
| Externally published | Yes |
Keywords
- Adenocarcinoma
- Cytoprotection
- TFF2